BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Consumer Health

Luye Pharma and Towa Pharmaceutical File NDA in Japan for Rivastigmine Twice Weekly Patch for Alzheimer’s

Luye Pharma Group announced that its partner Towa Pharmaceutical Co., Ltd. (Towa) has filed a New Drug Application (NDA) to the Ministry of Health, Labour ...

June 07, 2024 | News

Eisai and nippon medac Launch Metoject® Subcutaneous Injection Pen for Rheumatoid Arthritis in Japan

Eisai Co., Ltd. and nippon medac Co., Ltd., a subsidiary of the medac group, announced the launch of the anti-rheumatic agent "Metoject® Subcut...

May 23, 2024 | News

Elinzanetant Significantly Reduces Frequency and Severity of Moderate to Severe Hot Flashes Associated with Menopause

Bayer will present detailed results from the pivotal Phase III studies OASIS 1 and 2, showing that the investigational compound elinzanetant significantly ...

May 17, 2024 | News

Sciwind Biosciences and HK inno.N Forge Partnership to Bring New Diabetes Treatment to South Korea

Sciwind Biosciences Co., Ltd., a clinical stage biopharmaceutical company focused on developing treatments for metabolic disease, and HK inno.N Corporation...

May 07, 2024 | News

Bespak and H&T Presspart Join Forces to Drive Adoption of Climate-Friendly Inhaler Technology

Bespak, a leading contract development and manufacturing organisation (CDMO) focussed on orally inhaled and nasal drug-device combination products, and H&a...

May 06, 2024 | News

GSK Leads Adult Immunization Efforts in Malaysia for a Healthier Aging Population

As Malaysia's population shifts towards an ageing demographic, the importance of adult immunisation becomes increasingly apparent. By ensuring that individ...

April 26, 2024 | News

GSK's Trelegy Ellipta Gets Singapore HSA Approval for Asthma, Expands Beyond COPD.

GSK Singapore announced that the Health Sciences Authority (HSA) has approved a new indication and a new strength for Trelegy Ellipta (fluticasone fur...

April 08, 2024 | News

ZEISS Acquires D.O.R.C., Eyeing Future Innovations in Ophthalmology

This acquisition, now fully approved by regulatory bodies, not only expands ZEISS's ophthalmic portfolio but also reinforces its standing as a trailb...

April 05, 2024 | News

FDA Approves Vafseo for Anemia in Dialysis Patients

SL Vifor is pleased that its partner Akebia Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Vafseo (vadadustat) ...

March 29, 2024 | News

Grindr and Burnett Foundation Aotearoa Partner to Distribute Free HIV Test Kits in New Zealand

Grindr and Burnett Foundation Aotearoa Partner to Distribute Free HIV Test Kits in New Zealand Grindr Inc. (NYSE: GRND), the leading social networ...

March 25, 2024 | News

A New Dawn in Heart Care: Singapore Leads with Innovative CVD Prevention Plan

In an interaction with BioPharma APAC, Dr. Low Lip Ping, Chairman Emeritus of the Singapore Heart Foundation, sheds light on the critical f...

March 20, 2024 | Interaction

Bridging Gaps, Building Futures: Ruth Kuguru’s Approach to Healthcare Solutions in APAC

In this insightful interview with BioPharma APAC, Ruth Kuguru, Executive Director of Communications & Engagement at Novartis for Asia Pacific, Middle E...

March 05, 2024 | Interaction

Sparsentan Receives CHMP Endorsement for IgA Nephropathy Treatment in Europe

CSL Vifor together with Travere Therapeutics, Inc., disclosed that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CH...

February 26, 2024 | News

BD Partners with Camtech Health to Increase Access to Cervical Cancer Screening in Singapore

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced a strategic partnership with Camtech Health, a ...

February 22, 2024 | News

Stay Connected